Aura Biosciences, Inc.
SEC Filing List
AURA CIK: 0001501796
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/12/2026 | |||
| SCHEDULE 13D/A | PAUL WEISS RIFKIND WHARTON & GARRISON LLP 01/FA | 05/11/2026 | |||
| 4 | Statement of changes in beneficial owner... | PAUL WEISS RIFKIND WHARTON & GARRISON LLP 01/FA | 05/11/2026 | ||
| 10-Q | Quarterly report pursuant to Section 13 ... | Aura Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/11/2026 | |
| 8-K | Current report filing | Aura Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/11/2026 | |
| 3 | Initial statement of beneficial ownershi... | Holles Natalie C. | Aura Biosciences, Inc. | 05/07/2026 | |
| 8-K | Current report filing | Aura Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/05/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Aura Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/05/2026 | |
| 8-K | Current report filing | Aura Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| 8-K | Current report filing | Aura Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| No record found. | |||||
| Load More | |||||
